Why the study?
To evaluate the clinical value of plasma D-dimer/fibrinogen ratio in patients hospitalized for heart failure.
Does a higher plasma D-dimer/fibrinogen ratio (DFR) predict adverse outcomes in patients hospitalized for heart failure?
Does a higher plasma D-dimer/fibrinogen ratio (DFR) predict adverse outcomes in patients hospitalized for heart failure?
A higher plasma D-dimer/fibrinogen ratio is a reliable prognostic indicator for adverse outcomes, including readmission, thrombotic events, and death, in patients hospitalized for heart failure.
May aid risk stratification during HF hospitalization; leaves open incremental value beyond standard markers pending prospective validation.
Aim: To evaluate the clinical value of plasma D-dimer/fibrinogen ratio (DFR) in patients hospitalized for heart failure (HF). Methods: Clinical data of 235 patients were retrospectively analyzed. Kaplan–Meier method and Cox regression analysis were used to identify significant prognosticators. Results: The Kaplan–Meier analysis showed that a higher DFR level was significantly associated with an increase in the end point outcomes, including HF readmission, thrombotic events and death (log-rank test: p < 0.001). The multivariate Cox regression analysis showed that the high tertile of DFR was significantly associated with the study end points (HR: 2.18; 95% CI: 1.31–3.62; p = 0.003), compared with the low tertile. Conclusion: DFR is a reliable prognostic indicator for patients hospitalized for HF.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: